A Director at Trevena Inc (TRVN) is Buying Shares
Today, a Director at Trevena Inc (TRVN), Leon Moulder, bought shares of TRVN for $102K.
This recent transaction increases Leon Moulder’s holding in the company by 200% to a total of $151.5K. This is Moulder’s first transaction since reporting a Buy transaction on TSRO back in March 2018
See today’s analyst top recommended stocks >>
Based on Trevena Inc’s latest earnings report for the quarter ending September 30, the company posted quarterly revenue of $3 million and GAAP net loss of $4.48 million. In comparison, last year the company earned revenue of $0 and had a GAAP net loss of $14.72 million. Currently, Trevena Inc has an average volume of 30.42K.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Trevena, Inc. is a clinical stage biopharmaceutical company, which engages in the provision of healthcare services and development of therapies. The company product pipeline consists of Olinvo, TRV250, and TRV734.
Read More on TRVN: